Syndax Pharmaceuticals (SNDX) EBITDA Margin (2015 - 2026)
Syndax Pharmaceuticals (SNDX) recorded EBITDA Margin of -48.08% in Q2 2026, up 134.63 percentage points from -182.71% a year earlier but down 1.52 percentage points from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) EBITDA Margin (2015 - 2026) Analysis & Trends
On a TTM basis, Syndax Pharmaceuticals' EBITDA Margin came in at -86.54% as of Jun 30, 2026, up 146.29 percentage points year-over-year; for FY2025, it came in at -154.96%, up 1245.68 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +4547.28 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -1400.64% in FY2024 and 49.55% in FY2021 (+4751.79 pp).
- Quarterly EBITDA Margin has ranged from -417.91% in Q1 2025 to -46.56% in Q1 2026 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Syndax Pharmaceuticals | 1.68 Bn | -53.94 Mn | 69.58 Mn | -48.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.08% |
| Mar 31, 2026 | -46.56% |
| Jun 30, 2025 | -182.71% |
| Mar 31, 2025 | -417.91% |
| Sep 30, 2019 | -3,515.83% |
| Jun 30, 2019 | -4,115.57% |
| Mar 31, 2019 | -3,955.41% |
| Sep 30, 2018 | -4,745.65% |
| Jun 30, 2018 | -5,020.05% |
| Mar 31, 2018 | -5,227.70% |
| Sep 30, 2017 | -5,013.77% |
| Jun 30, 2017 | -4,514.43% |
| Mar 31, 2017 | -4,318.36% |
| Sep 30, 2016 | -5,018.69% |
| Jun 30, 2016 | -2,829.51% |
| Mar 31, 2016 | -2,852.46% |
| Sep 30, 2015 | -1,858.36% |
| Jun 30, 2015 | -31,594.12% |
API Access
Syndax Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();